Highlights and Quick Summary
- Average Payables for the quarter ending September 30, 2022 was $11.1 Million (a -28.69% decrease compared to previous quarter)
- Year-over-year quarterly Average Payables increased by 6.55%
- Annual Average Payables for 2021 was $10.4 Million (a 17.04% increase from previous year)
- Annual Average Payables for 2020 was $8.9 Million (a -20.41% decrease from previous year)
- Annual Average Payables for 2019 was $11.2 Million (a 44.18% increase from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Payables of BridgeBio Pharma, Inc.
Most recent Average Payablesof BBIO including historical data for past 10 years.Interactive Chart of Average Payables of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Average Payables for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $11.1 | $15.56 | $10.22 | – |
| 2021 | $10.41 | $10.94 | $17.58 | $11.71 | $10.41 |
| 2020 | $8.9 | $10.05 | $13.17 | $11.54 | $8.9 |
| 2019 | – | – | $8.93 | $10.05 | $11.18 |
| 2018 | – | – | – | $13.17 | $7.75 |
| 2017 | – | – | – | – | $8.0 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology